BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
56.24
-1.53 (-2.65%)
Sep 8, 2025, 11:05 AM - Market open
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
24
Consensus Rating
Buy
Price Target
$91.70
Upside
+63.05%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $60 | Hold | Initiates | $60 | +6.69% | Sep 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $101 → $106 | Strong Buy | Maintains | $101 → $106 | +88.48% | Aug 6, 2025 |
| UBS | UBS | Strong Buy Maintains $113 → $114 | Strong Buy | Maintains | $113 → $114 | +102.70% | Aug 5, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $97 → $96 | Buy | Maintains | $97 → $96 | +70.70% | Jul 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $108 → $113 | Buy | Maintains | $108 → $113 | +100.92% | Jul 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $124 → $104 | Strong Buy | Maintains | $124 → $104 | +84.92% | May 5, 2025 |
| Citigroup | Citigroup | Hold Maintains $82 → $78 | Hold | Maintains | $82 → $78 | +38.69% | May 2, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $98 | Hold → Buy | Upgrades | $98 | +74.25% | Feb 24, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $78 → $80 | Hold | Maintains | $78 → $80 | +42.25% | Feb 20, 2025 |
| Citigroup | Citigroup | Hold Maintains $81 → $82 | Hold | Maintains | $81 → $82 | +45.80% | Feb 20, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $70 | Hold | Reiterates | $70 | +24.47% | Feb 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +60.03% | Feb 20, 2025 |
| UBS | UBS | Strong Buy Maintains $109 → $113 | Strong Buy | Maintains | $109 → $113 | +100.92% | Feb 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $122 → $126 | Buy | Maintains | $122 → $126 | +124.04% | Feb 20, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $99 → $103 | Strong Buy | Maintains | $99 → $103 | +83.14% | Feb 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +60.03% | Dec 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.